Convertible Issue

Apellis crosses the finish line – now to pay it back

Invitae borrows against the future

Cancer diagnosis is likely to see a huge resurgence in demand as the pandemic ebbs, and Invitae wants to be ready.

May 21, 2019

Aegerion’s poisoned chalice gives Amryt some distraction therapy

Three years after being merged with QLT the Aegerion business is to be sold out of bankruptcy protection.

February 22, 2019

Trillium punishes its investors

March 14, 2018

Debt comes back to haunt biotech

August 10, 2017

Cempra and Melinta’s lesson in value destruction

February 16, 2017

Clozel’s takeover masterclass

November 22, 2016

Pharming bets the house on Ruconest

August 10, 2016

A new Valeant starts to take shape, and it's still not pretty

June 27, 2016

As Brexit hits forex, spare a thought for those uncompleted deals

June 16, 2016

QLT and Aegerion put each other out of their miseries

Load More